Advertisement
Review Article| Volume 365, ISSUE 4, P321-328, April 2023

Download started.

Ok

PACK syndrome: A case series and review

  • B. Collins
    Correspondence
    Corresponding author at. B. Collins, DO, 96 Jonathan Lucas Street, Suite 822, Charleston, SC 29425, USA.
    Affiliations
    Department of Medicine, Medical University of South Carolina, Charleston, SC, USA

    Division of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
  • D. Dillon
    Affiliations
    Department of Medicine, Medical University of South Carolina, Charleston, SC, USA

    Division of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
  • R.M. Silver
    Affiliations
    Department of Medicine, Medical University of South Carolina, Charleston, SC, USA

    Division of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
Published:December 16, 2022DOI:https://doi.org/10.1016/j.amjms.2022.12.005

      Abstract

      A rare overlap syndrome between CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome and primary biliary cholangitis (PBC) is described as PACK syndrome, an acronym for primary biliary cholangitis, anticentromere antibodies, CREST syndrome, and keratoconjunctivitis sicca. In this retrospective cohort analysis and review, we present fourteen patients who meet diagnostic criteria for PACK syndrome in one of the largest case series of this group. All patients were female, 86% of whom were White with an average age of 66.7 years (range 39-78 years). The prevalence was 5.08% in our PBC cohort (n=256) similar to previous findings. CREST syndrome was diagnosed prior to PBC in 58% of our patients and limited pulmonary and renal involvement were observed. This syndrome is rare, but given its insidious development, clinicians should be aware of this potential overlap in CREST-only and PBC-only patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Van Den Hoogen F
        • Khanna D
        • Fransen J
        • et al.
        2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
        Ann Rheum Dis. 2013; 72: 1747-1755https://doi.org/10.1136/annrheumdis-2013-204424
        • Wollheim FA.
        Classification of systemic sclerosis. Visions and reality.
        Rheumatology. 2005; 44: 1212-1216https://doi.org/10.1093/rheumatology/keh671
        • Thibièrge G
        • Weissenbach A.
        Concretions calcaires sous-cutanees et sclerodermie.
        Ann Dermat Syph. 1911; 2: 129-155
        • Winterbauer RH.
        Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly, and subcutanious calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia.
        Bull Johns Hopkins Hosp. 1964; 114: 361-383
        • Sherlock S
        • Scheuer P.
        The presentation and diagnosis of 100 patients with primary biliary cirrhosis.
        N Engl J Med. 1973; 289: 674-678
        • Bogdanos D
        • Baum H
        • Vergani D.
        Antimitochondrial and other autoantibodies.
        Clin Liver Dis. 2003; 7: 759-777
        • Metcalf J
        • Mitchison H
        • Palmer J
        • Jones D
        • Bassendine M
        • James O.
        Natural history of early primary biliary cirrhosis.
        Lancet. 1996; 348: 1399-1402https://doi.org/10.1157/13127093
        • Floreani A
        • Cazzagon N.
        PBC and related extrahepatic diseases.
        Best Pract Res Clin Gastroenterol. 2018; 34-35: 49-54https://doi.org/10.1016/j.bpg.2018.05.013
        • Chalifoux SL
        • Konyn PG
        • Choi G
        • Saab S.
        Extrahepatic manifestations of primary biliary cholangitis.
        Gut Liver. 2017; 11: 771-780https://doi.org/10.5009/gnl16365
        • Nakamura T
        • Higashi S
        • Tomoda K
        • Tsukano M
        • Sugi K.
        Primary biliary cirrhosis (PBC) - CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction.
        Clin Rheumatol. 2007; 26: 596-600https://doi.org/10.1007/s10067-005-0178-x
        • Murray-Lyon M
        • Thompson R
        • Ansell D
        • Williams R.
        Scleroderma and primary biliary cirrhosis.
        Br Med J. 1970; 3: 258-259https://doi.org/10.1136/bmj.3.5721.526-c
        • Reynolds TB
        • Denison EK
        • Frankl HD
        • Lieberman FL
        • Peters RL.
        Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. new syndrome.
        Am J Med. 1971; 50: 302-312https://doi.org/10.1016/0002-9343(71)90218-X
        • Powell FC
        • Schroeter AL
        • Dickson ER.
        Primary biliary cirrhosis and the Crest syndrome: a report of 22 cases.
        Q J Med. 1987; 62: 75-82https://doi.org/10.1093/oxfordjournals.qjmed.a068082
        • Lindor KD
        • Bowlus CL
        • Boyer J
        • Levy C
        • Mayo M
        Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases.
        Hepatology. 2019; 69: 394-419https://doi.org/10.1002/hep.30145
        • Kouraklis G
        • Glinavou A
        • Karatzas G.
        Primary biliary cirrhosis accompanied by CREST syndrome.
        South Med J. 2002; 95: 1058-1059https://doi.org/10.1097/00007611-200295090-00021
        • Launay D
        • Hebbar M
        • Janin A
        • Hachulla E
        • Hatron PY
        • Devulder B.
        Cirrhose biliaire primitive et sclerodermie systemique (syndrome de Reynolds): a propos de huit nouveaux cas. Apport de la biopsie des glandes salivaires accessoires.
        Rev Med Interne. 1998; 19: 393-398https://doi.org/10.1016/S0248-8663(98)80863-1
        • Okano Y
        • Nishikai M
        • Scleroderma Sato A.
        primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease.
        Ann Rheum Dis. 1984; 43: 520-522https://doi.org/10.1136/ard.43.3.520
        • O'Brien S
        • Eddy W
        • Krawitt E.
        Primary biliary cirrhosis associated with scleroderma.
        Gastroenterology. 1972; 62: 118-121
        • Bartholomew LG
        • Caine JC
        • Winkelmann R
        • Baggenstoss AH.
        Chronic disease of the liver associated with systemic scleroderma.
        Am J Dig Dis. 1964; 9: 43-55https://doi.org/10.1007/BF02232678
        • Stadie V
        • Wohlrab J
        • Marsch W.
        The Reynolds’ syndrome- a rare combination of two autoimmune diseases.
        Med Klin. 2002; 97: 40-43
        • Akimoto S
        • Ishikawa O
        • Muro Y
        • Takagi H
        • Tamura T
        • Miyachi Y.
        Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone.
        J Dermatol. 1999; 26: 18-22
        • Marí-Alfonso B
        • Simeón-Aznar CP
        • Guillén-Del Castillo A
        • et al.
        Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the spanish RESCLE registry.
        Semin Arthritis Rheum. 2018; 47: 849-857https://doi.org/10.1016/j.semarthrit.2017.10.004
        • Akimoto S
        • Ishikawa O
        • Takagi H
        • Miyachi Y.
        Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone.
        J Gastroenterol Hepatol. 1998; 13: 897-901https://doi.org/10.1111/j.1440-1746.1998.tb00758.x
        • González-Huezo MS
        • Delgado-Ayala LY
        • Osorio-Núñez AL
        • Meléndez-Mercado C.
        Autoimmune associations in a Mexican cohort with primary biliary cholangitis.
        Rev Gastroenterol México. 2019; 84: 130-135https://doi.org/10.1016/j.rgmxen.2018.09.003
        • Watt FE
        • James OFW
        • Jones DEJ.
        Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study.
        Q J Med. 2004; 97: 397-406https://doi.org/10.1093/qjmed/hch078
        • Floreani A
        • Franceschet I
        • Cazzagon N.
        Primary biliary cirrhosis: overlaps with other autoimmune disorders.
        Semin Liver Dis. 2014; 34: 352-360https://doi.org/10.1055/s-0034-1383734
        • Zheng B
        • Vincent C
        • Fritzler MJ
        • Senécal JL
        • Koenig M
        • Joyal F.
        Prevalence of systemic sclerosis in primary biliary cholangitis using the New ACR/EULAR classification criteria.
        J Rheumatol. 2017; 44: 33-39https://doi.org/10.3899/jrheum.160243
        • Assassi S
        • Fritzler MJ
        • Arnett FC
        • et al.
        Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
        J Rheumatol. 2009; 36: 2250-2256https://doi.org/10.3899/jrheum.090340
        • Norman GL
        • Bialek A
        • Encabo S
        • et al.
        Is prevalence of PBC underestimated in patients with systemic sclerosis?.
        Dig Liver Dis. 2009; 41: 762-764https://doi.org/10.1016/j.dld.2009.01.014
        • Marasini B
        • Gagetta M
        • Rossi V
        • Ferrari P.
        Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients.
        Ann Rheum Dis. 2001; 60: 1046-1049https://doi.org/10.1136/ard.60.11.1046
        • Bennett RM.
        Scleroderma overlap syndromes.
        Rheum Dis Clin North Am. 1990; 16: 185-198
        • Raine C
        • Canning B
        • Marks J
        • Donnelly S
        • Ong V
        • Tahir H.
        Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitis.
        Eur J Rheumatol. 2018; 5: 269-271https://doi.org/10.5152/eurjrheum.2018.17177
        • Oddis CV.
        • Eisenbeis CH
        • Reidbord H
        • Steen VD.
        Vasculits in systemic sclerosis: association with Sjogren's syndrome and the CREST syndrome variant.
        J Rheumatol. 1987; 14: 942-948
        • Steen VD.
        Autoantibodies in systemic sclerosis.
        Semin Arthritis Rheum. 2005; 35: 35-42https://doi.org/10.1016/j.semarthrit.2005.03.005
        • Bernstein RM
        • Callender ME
        • Neuberger JM
        • Hughes GR
        • Williams R.
        Anticentromere antibody in primary biliary cirrhosis.
        Ann Rheum Dis. 1982; 41: 612-614https://doi.org/10.1136/ard.41.6.612
        • Shoji I
        • Takagi T
        • Kasukawa R.
        Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.
        Intern Med. 1992; 31: 1348-1355
        • Abraham S
        • Begum S
        • Isenberg D.
        Hepatic manifestations of autoimmune rheumatic diseases.
        Ann Rheum Dis. 2004; 63: 123-129https://doi.org/10.1136/ard.2002.001826
        • Liberal R
        • Grant CR
        • Sakkas L
        • Bizzaro N
        • Bogdanos DP.
        Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis.
        Clin Res Hepatol Gastroenterol. 2013; 37: 572-585https://doi.org/10.1016/j.clinre.2013.04.005
        • Fritzler MJ
        • Kinsella TD
        • Garbutt E.
        The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
        Am J Med. 1980; 69: 520-526https://doi.org/10.1016/0002-9343(80)90462-3
        • Lepri G
        • Bellando Randone S
        • Matucci Cerinic M
        • Allanore Y
        Systemic sclerosis and primary biliary cholangitis: an overlapping entity?.
        J Scleroderma Relat Disord. 2018; 4: 111-117
        • Mccarty GA
        • Rice JR
        • Bembe ML
        • Barada Jr, FA
        Anticentromere antibody: clinical correlations and association with favorable prognosis in patients with scleroderma variants.
        Arthritis Rheum. 1983; 26: 1-7
        • Rigamonti C
        • Bogdanos DP
        • Mytilinaiou MG
        • Smyk DS
        • Rigopoulou EI
        • Burroughs AK.
        Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.
        Int J Rheumatol. 2011; 2011https://doi.org/10.1155/2011/976427
        • Abu-shakra M
        • Lee P.
        Mortality in systemic sclerosis: a comparison with the general population.
        J Rheumatol. 1995; 22: 2100-2102
        • Rigamonti C
        • Shand LM
        • Feudjo M
        • et al.
        Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis.
        Gut. 2006; 55: 388-394https://doi.org/10.1136/gut.2005.075002